Insulin Dose of 0.1 Units/kg for Triglyceride Reduction
A single subcutaneous dose of regular insulin at 0.1 units/kg can achieve immediate triglyceride reduction in severe hypertriglyceridemia, though the exact magnitude varies—one case report demonstrated effectiveness in bringing levels from >4500 mg/dL toward safer ranges, while continuous IV infusion protocols (not single doses) typically achieve levels <1000 mg/dL within approximately 39 hours.
Context and Mechanism
The 0.1 units/kg dose works through multiple mechanisms 1:
- Blocks adipose tissue lipolysis, reducing circulating free fatty acids
- Reduces hepatic triglyceride production
- Increases lipoprotein lipase (LPL) activity, accelerating triglyceride clearance from plasma
Evidence for the 0.1 Units/kg Dose
Single-Dose Subcutaneous Administration
The most direct evidence comes from a case report where 0.1 units/kg subcutaneous regular insulin achieved immediate triglyceride reduction in a non-diabetic adolescent with severe hypertriglyceridemia (initial level 4575 mg/dL) 2. This single dose was effective for acute reduction, though it could not maintain levels below 1000 mg/dL long-term without additional therapy.
Continuous Infusion Protocols
For intravenous continuous infusion (a different context than your question), the standard DKA dose is 0.1 units/kg/hour 3. A recent protocol using weight-based fixed-dose insulin infusions achieved:
- Triglyceride levels <1000 mg/dL within median 39 hours (IQR 23-59 hours)
- Triglyceride levels <500 mg/dL within median 62 hours (IQR 38.5-74.5 hours) 4
Important Clinical Caveats
Guideline Recommendations Are Cautious
The 2020 Endocrine Society guidelines suggest AGAINST routine insulin infusion for TG-induced pancreatitis in non-diabetic patients (weak recommendation, very low-quality evidence) 1. The rationale:
- Limited data supporting superiority over simply stopping oral fat intake
- Unclear whether insulin adds benefit beyond fasting alone
- Low-dose insulin (1-2 units/hour) may be considered judiciously, but high doses (>0.1 units/kg/hour) risk hypoglycemia
Safety Concerns with 0.1 Units/kg
- Hypoglycemia risk: This dose, particularly when used as DKA dosing (>0.1 units/kg), significantly increases hypoglycemia risk 1
- Counterproductive glucose infusion: If glucose is given concurrently to prevent hypoglycemia, the carbohydrate load may paradoxically increase hepatic triglyceride production 1
- In non-hyperglycemic patients, much lower doses (1-2 units/hour total, not per kg) are typically sufficient to suppress lipolysis 1
Practical Algorithm
For severe hypertriglyceridemia (>1000 mg/dL) with pancreatitis risk:
First-line: Immediate cessation of oral fat intake (triglycerides fall rapidly without additional chylomicron entry) 1
If diabetes/hyperglycemia present: Use insulin to normalize glucose (standard diabetes management doses) 1
If non-diabetic with inadequate response: Consider low-dose insulin infusion (1-2 units/hour total, NOT per kg) to suppress lipolysis 1
Single subcutaneous dose option: 0.1 units/kg regular insulin may provide immediate reduction but requires close glucose monitoring and is not guideline-recommended as routine therapy 2
Reserve plasmapheresis: Only for extraordinarily elevated levels (>10,000 mg/dL) or failure of conventional methods 1
Bottom Line on Magnitude of Effect
There is no precise, quantifiable answer to "how much will 0.1 units/kg lower TG" because:
- The single published case used this dose but didn't report exact numerical reduction 2
- Continuous infusion studies use different dosing paradigms (per hour vs. single dose)
- Individual response varies based on underlying cause, baseline TG level, concurrent fasting, and insulin sensitivity
The best available evidence suggests this dose achieves clinically meaningful acute reduction in severe cases, but guidelines favor fasting alone or very low-dose continuous infusion over bolus dosing in non-diabetic patients.